During the past decade, University Hospial of Mannheim conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "University Hospial of Mannheim" are "Malignant Melanoma" (2 trials). Many other conditions were trialed in "University Hospial of Mannheim" in a lesser frequency.

Most popular intervention types in "University Hospial of Mannheim" are "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "CancerVax vaccine (CANVAXIN)" (2 trials). Other intervention names were less common.

The vast majority of trials in "University Hospial of Mannheim" are 2 trials for "All" genders.

Currently, there are NaN active trials in "University Hospial of Mannheim". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in University Hospial of Mannheim, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in University Hospial of Mannheim, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".